Sponsored by

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1126 to 1150 of about 5880

Previous 25

Website Changes

02/13/2019

Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema.

02/13/2019

Race influences survival in glioblastoma patients with KPS =?80 and associates with genetic markers of retinoic acid metabolism.

02/13/2019

Oncotelic Reports that It`s Proprietary In-Situ Cancer Vaccine Improved Survival over Standard Chemotherapy in Patients with Recurrent Metastatic Pancreas Cancer and Recurrent High Grade Glioma

02/12/2019

Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review

02/12/2019

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.

02/11/2019

Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1 Brain Cancer Trial

02/10/2019

Medicenna Presents Promising Clinical Data from Phase 2b Recurrent Glioblastoma Trial of MDNA55

02/06/2019

Brain Tumor `Pied Piper` Device Gains Breakthrough Status

02/05/2019

Moleculin Biotech (MBRX) Announces FDA Orphan Drug Designation for its Brain Tumor Drug

01/31/2019

GT Medical Technologies Announces Publication of Data Showing Company’s Targeted Therapy is Effective for Treating Recurrences of Common Type of Brain Tumor

01/30/2019

Musella Foundation awards a pediatric brain tumor research grant!

01/26/2019

Early clinical trials of Toca 511 and Toca FC show a promising novel treatment for recurrent malignant glioma.

01/26/2019

The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma.

01/26/2019

Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells.

01/26/2019

Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial

01/26/2019

Effect of health disparities on overall survival of patients with glioblastoma.

01/25/2019

New Liquid Biopsy Test Detects Brain Cancer, But It Doesn`t Use Blood

01/23/2019

Regorafenib Doubles 12-Month Survival Compared with Lomustine in Recurrent GBM

01/22/2019

Dexamethasone—Friend or Foe for Patients With Glioblastoma?

01/19/2019

Activation of dopamine receptor 2 (DRD2) prompts transcriptomic and metabolic plasticity in glioblastoma.

01/18/2019

Optune Open House, Newton, MA

01/14/2019

Copay assistance program is now open!

01/11/2019

Publication Reports Role of Dopamine Receptors in Cancer and ONC201 Response

01/09/2019

Musella Foundation awards 2 grants!

01/09/2019

ERC-USA Initiates Therapy Under Right to Try Law With First Patient In California Using Investigational Compound ERC1671 for Treatment of Glioblastoma

Our privacy / cookie policy has changed.
Click HERE to read it!